Oh fun trivia about those straightforward engineering problems was Novartis beavu. It had a few percent higher Side Effects than standard of care after lunch. This was enough to cause Novartis (a top 5 or 10 Pharma company) to essentially cease all ocular drug research and sell off much of their ocular portfolio.
